Background and Objective: Hemodialysis through temporary catheters in the femoral vein is essential
for patients with End-Stage Renal Disease (ESRD) requiring urgent vascular access. This study evaluates the
efficacy and safety of two different catheter lengths (20 cm and 24 cm) to determine the optimal clinical
choice. The aim is to compare two catheters in an effort to identify one with lower malfunction rates,
reduced infection incidence, and improved long-term efficacy in ESRD patients.
Materials & Methods: In this randomized controlled clinical trial, 80 ESRD patients in need of
temporary hemodialysis were randomly assigned to receive either a 20 cm or 24 cm femoral catheter.
Patients were monitored over two weeks for catheter performance and complications, including infection,
thrombosis, and hematoma.
Results: Among 80 patients (53 men [66.25%], 27 women [33.75%]), the mean age was 52.5 ± 13.7 years
in the 20 cm group and 56.0 ± 12.9 years in the 24 cm group. Demographics were statistically similar. The
most common complication was thrombosis (23.75%); observed in 17.5% of the 20 cm group and 30% of the
24 cm group. Infections occurred in 20% of the 20 cm group and 12.5% of the 24 cm group. Hematomas were
seen in 20% of the 20 cm group and 7.5% of the 24 cm group. Catheter functionality at two weeks was 65% in
the 20 cm group and 60% in the 24 cm group (P = 0.712).
Conclusion: Both catheter lengths demonstrated similar performance and complication rates over the
two-week period. Catheter selection can beindividualized based on patient-specific factors, as both sizes
offer acceptable efficacy and safety profiles.